About ARTMS
ARTMS is a company based in Vancouver (Canada) founded in 2013 was acquired by Telix Pharma in March 2024.. ARTMS has raised $26.58 million across 5 funding rounds from investors including GF Securities, Telix Pharmaceuticals and Innovate BC. ARTMS operates in a competitive market with competitors including NorthStar Medical Radioisotopes, Niowave, Nanovista, Ground Fluor Pharmaceuticals and ATOMIC ALCHEMY, among others.
- Headquarter Vancouver, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$26.58 M (USD)
in 5 rounds
-
Latest Funding Round
$300 K (USD), Grant
Feb 24, 2021
-
Investors
GF Securities
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Telix Pharma
(Mar 05, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ARTMS
ARTMS has successfully raised a total of $26.58M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $300 thousand completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $300,000
-
First Round
First Round
(01 Jun 2017)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Grant - ARTMS | Valuation |
investors |
|
| May, 2020 | Amount | Series A - ARTMS | Valuation | Deerfield | |
| Aug, 2019 | Amount | Series A - ARTMS | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ARTMS
ARTMS has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include GF Securities, Telix Pharmaceuticals and Innovate BC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startup accelerator firm backed by the British Columbia Government
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Tech & Life Sciences focused early stage VC firm investing in North America
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ARTMS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ARTMS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Artms Comparisons
Competitors of ARTMS
ARTMS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NorthStar Medical Radioisotopes, Niowave, Nanovista, Ground Fluor Pharmaceuticals and ATOMIC ALCHEMY, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
|
|
| domain | founded_year | HQ Location |
Devices and radioisotopes for nuclear imaging are provided by Niowave.
|
|
| domain | founded_year | HQ Location |
Multimodal visualization agents are developed for image-guided interventions.
|
|
| domain | founded_year | HQ Location |
Proprietary chemistry for pharmaceutical synthesis is developed by the company.
|
|
| domain | founded_year | HQ Location |
Limited information available
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Artms
Frequently Asked Questions about ARTMS
When was ARTMS founded?
ARTMS was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Where is ARTMS located?
ARTMS is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Who is the current CEO of ARTMS?
Charles Conroy is the current CEO of ARTMS.
Is ARTMS a funded company?
ARTMS is a funded company, having raised a total of $26.58M across 5 funding rounds to date. The company's 1st funding round was a Series A of $1.5M, raised on Jun 01, 2017.
What does ARTMS do?
ARTMS was founded in 2013 in Vancouver, Canada. The company operates in the radioisotope sector, where technologies for medical and research applications are developed. Services are extended to support radioisotope material creation by developers. The QIS system is utilized for turnkey production of purified radiometals. Focus is placed on enabling production processes within the healthcare isotope industry from a Canadian base.
Who are the top competitors of ARTMS?
ARTMS's top competitors include NorthStar Medical Radioisotopes, Niowave and ATOMIC ALCHEMY.
Who are ARTMS's investors?
ARTMS has 5 investors. Key investors include GF Securities, Telix Pharmaceuticals, Innovate BC, Deerfield, and Quark Venture.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.